Abstract
5-Fluorouracil(5-FU)isusedwidelyasananticancerdrugtotreatsolidcancers,suchascolon,breast,rectal,andpancreaticcancers;althoughitsclinicalapplicationislimitedbecause5-FUhasgastrointestinalandhematologicaltoxicity.Anapproachtoimprovethecancercellselectivepropertiesof5-fluorouracilisthechemicaltransformationintoreversiblederivatives(prodrugs)whichareconvertedtotheparentdrugbyvirtueofenzymaticand/orchemicalhydrolysiswithinthecancertissue.Inthepresentstudy,threederivativesof5-fluorouracilhasbeendesignedtobesynthesizedas5-fluorouracilphosphoramidateprodrugs,compounds(I,IIandIII)toselectivelydeliverthe5-fluorouracilintothecancercells.ThegenerationofthetargetcompoundsI,IIandIIIwereaccomplishedfollowingone-potreactionprocedures.ThereactionandpurityoftheproductswerecheckedbyTLC,thestructureofthefinalcompoundswasconfirmedbytheirmeltingpoints,infraredspectroscopyandelementalmicroanalysis.ThehydrolysisofcompoundsI,IIandIIIinaqueousbuffersolutionofpH6,pH7.4andinserumwerestudied.CompoundsI,IIandIIIhadacceptablerateofhydrolysisatpH6(t=45.05min,t=41.22minand t=38.80minrespectively)andenoughstabilityatpH7.4(t=348.72min,t=395.31minand t=345.38minrespectively);andenoughstabilityatserum;thereforethesethreecompoundscanselectivelydeliver5-fluorouracilintothetumorcellswhichhavepHapproximateto(6).Accordingtotheresultsmentionedabove,compoundsI,IIandIIIcanbegoodcandidatesas5-fluorouracilprodrugsthatcanselectivelydelivertheparentdrugintothecancercellsbytheeffectofpHand/orenzyme
Keywords
5-Fluorouracil
Cancer targeting
Phosphoramidate prodrug